ArticlePloS one2010

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.

Michael Nowak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.